Half of Americans May Be Candidates for Ozempic

Published on November 19, 2024

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide, a new analysis finds. Sold as Ozempic for treating diabetes and Wegovy to spur weight loss, the medication could be indicated for those two…

Read Full Article (External Site)